ACADIA Pharmaceuticals

San Diego, CA

Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

acadia-pharm.com

Claim this profile

Employbl Premium

Get the inside track on ACADIA Pharmaceuticals

Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.

AI chat about ACADIA Pharmaceuticals's culture, stack, and interview process
Save jobs and get alerts on new openings
Full premium profiles across our company index
7-day free trial, then $25/mo. Cancel anytime.

Start free trial →Already have an account? Sign in

Company Details

Founded: 1993
Employees: 654 employees
Raised: $811,734,976
Headquarters Location: San Diego, CA
Public: Yes
Acquired: No
CEO: Steve Davis
Founders: Mark R. Brann

Company Collections

These are collections ACADIA Pharmaceuticals is a part of. Click on the collection name to view similar companies.

ACADIA Pharmaceuticals' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

ACADIA Pharmaceuticals' Tech Stack

Microsoft Azure

Current Job Listings

Listing 0 of 47 job openings

ACADIA Pharmaceuticals Headquarters Location

12830 El Camino Real Suite 400, San Diego, CA, 92130-3331

Loading map…

Total Amount Raised: $811,734,976

ACADIA Pharmaceuticals Funding Rounds

Post Ipo Equity
$287,500,000
Sep 17, 2019
Post Ipo Equity
$287,500,000
Sep 16, 2019
Post Ipo Equity
$316,249,997
Nov 30, 2018
Post Ipo Equity
$316,249,997
Nov 29, 2018
Post Ipo Equity
$86,385,000
Jan 2, 2013
Post Ipo Equity
$86,385,000
Jan 1, 2013
Grant
$2,400,000
May 17, 2011
Grant
$2,400,000
May 16, 2011
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)
Post Ipo Equity
$15,000,000
Jan 11, 2011
Post Ipo Equity
$15,000,000
Jan 10, 2011
Post Ipo Equity Investors
Venrock
NEA - New Enterprise Associates
Post Ipo Equity
$20,000,000
Feb 7, 2006
Post Ipo Equity
$20,000,000
Feb 6, 2006
Post Ipo Equity Investors
Nomura Holdings
Oxford Bioscience Partners
Post Ipo Equity
$10,000,000
Feb 8, 2005
Post Ipo Equity
$10,000,000
Feb 7, 2005
Post Ipo Equity Investors
Oxford Bioscience Partners
Series F
$25,000,000
Mar 31, 2003
Series F
$25,000,000
Mar 30, 2003
Series F Investors
Oxford Bioscience Partners
OrbiMed Advisors
LD Pensions
Tekla Capital Management
ABN AMRO Fund
Federated Investors
Forbion Capital Partners
Debt Financing
$22,000,000
Jun 20, 2000
Debt Financing
$22,000,000
Jun 19, 2000
Debt Financing Investors
Tekla Life Sciences Investors
The Kaufman Fund
DKA Capital
Pacific Rim Ventures
OrbiMed Advisors
Series D
$10,700,000
Aug 31, 1998
Series D
$10,700,000
Aug 30, 1998
Series D Investors
LD Pensions
DKA Capital
Series B
$3,000,000
Aug 13, 1997
Series B
$3,000,000
Aug 12, 1997
Series B Investors
BankInvest
LD Pensions
DKA Capital
Series A
$6,000,000
Feb 4, 1997
Debt Financing
$7,500,000
Feb 4, 1997
Series A
$6,000,000
Feb 3, 1997
Series A Investors
BankInvest
LD Pensions
DKA Capital
Debt Financing
$7,500,000
Feb 3, 1997
Debt Financing Investors
Vækstfonden
IPO
Unknown
Jan 1, 1985

Funding info provided by Diffbot.

ACADIA Pharmaceuticals Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ACADIA Pharmaceuticals.